BRCA1 and gastric carcinoma: This included KE39, a gastric carcinoma cell line that is homozygous for a missense mutation in BRCA1 (Y1853C) but was not originally labeled as BRCA1/2-deficient because this mutation was not deemed damaging by our initial criteria (see “Materials and Methods”).